Preclinical mouse model study showed that anti-PD-1 expanded the exhausted and unconventionally activated T cells, such as CXCR6+PD-1+CD8+ T cells, which lost the immune surveillance function and promoted NASH-HCC progression. Here, PDCD1 is linked to hepatocellular carcinoma.